Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers.

(e) On June 17, 2020, the Compensation Committee of the Board of Directors of ERBA Diagnostics, Inc. (the "Company"), as well as the independent directors on the Board of Directors of the Company, approved a one-time payment to David Barka, the Company's Interim Chief Executive Officer, in the amount of one hundred fifty thousand dollars ($150,000), payable June 18, 2020, for the services he has provided as the Company's Interim Chief Executive Officer and approved a one-time retainer for Mr. Barka in the amount of one hundred fifty thousand dollars ($150,000), payable July 2, 2020, for his continued services as the Company's Interim Chief Executive Officer.

As previously reported, since Mr. Barka's appointment as the Company's Interim Chief Executive Officer in July 2017, the Company has not paid Mr. Barka any compensation for his services as the Company's Interim Chief Executive Officer, because, in addition to serving as the Company's Interim Chief Executive Officer, Mr. Barka has also served, and continues to serve, as President of Calbiotech, Inc., President of Calbiotech Veterinary Diagnostics, and President of Microplate Dispensers, Inc. d/b/a Moduline Systems, all of which are direct or indirect subsidiaries of Erba Diagnostics Mannheim GmbH, the majority stockholder of the Company ("Erba Mannheim").

Mr. Barka continues to serve as the Company's Interim Chief Executive Officer and oversees the business and operations of the Company and its wholly owned subsidiaries. As the Company's Interim Chief Executive Officer, Mr. Barka's continuing role is also expected to include, among other things, assisting the Company in its efforts to find and train a permanent successor to the role of the Company's Chief Executive Officer. Mr. Barka's employment with the Company continues to be at-will and may be terminated by the Company or by Mr. Barka at any time for any reason or for no reason.

As previously reported, Erba Mannheim beneficially owns, directly or indirectly, approximately 83.3% of the outstanding shares of the Company's common stock. As also previously reported, the Company and its wholly owned subsidiaries, on the one hand, and Erba Mannheim and its affiliates, on the other hand, have engaged in and are currently engaged in a number of commercial transactions.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses